No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Biomark Diagnostics Inc: MDA EN
Biomark Diagnostics Inc: AUDITED ANNUAL FINANCIAL STATEMENTS EN
BioMark Partners With Rubix LS to Advance Blood-Based Cancer Screening in Underserved Communities
Theresa Peterson Joins Biomark's Advisory Team
BioMark Announces Closing of $1.9 Million Non-Brokered Private Placement
BioMark Provides Second Quarter Operational Update and Announces Extension to Warrant Exercise Term